Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/new-versus-established-drugs-in-venous-thromboprophylaxis-rOaG9D4WvD
References (54)
-
D. Bergqvist, U. Burmark, J. Frisell, T. Hallböök, B. Lindblad, B. Risberg, S. Törngren, G. Wallin (1986)
Low molecular weight heparin once daily compared with conventional low‐dose heparin twice daily. A prospective double‐blind multicentre trial on prevention of postoperative thrombosisBritish Journal of Surgery, 73
-
C. Colwell, L. Kwong, A. Turpie, B. Davidson (2006)
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.The Journal of arthroplasty, 21 1
-
Bengt Eriksson, Giancarlo Agnelli, A. Cohen, O. Dahl, M. Lassen, P. Mouret, Nadia Rosencher, P. Kälebo, S. Panfilov, C. Eskilson, M. Andersson (2003)
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyJournal of Thrombosis and Haemostasis, 1
-
G. Agnelli (2003)
Prevention of venous thromboembolism in high risk abdominal surgeryHaematologica, 88
-
O. Dahl, B. Eriksson, G. Agnelli, A. Cohen, P. Mouret, N. Rosencher, S. Panfilov, A. Bylock, M. Andersson (2005)
Postoperative Melagatran/ Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic SurgeryClinical Drug Investigation, 25
-
G. Molenberghs, T. Burzykowski, Ariel Alonso, M. Buyse (2004)
A perspective on surrogate endpoints in controlled clinical trialsStatistical Methods in Medical Research, 13
-
J. Sharnoff, Guido Deblasio (1970)
Prevention of fatal postoperative thromboembolism by heparin prophylaxis.Lancet, 2 7681
-
B.I. Eriksson, G. Agnelli, A.T. Cohen (2003)
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacementThromb Haemost, 89
-
Blood Coagulation, Fibrinolysis and Cellular Haemostasis -
G. Olsson, J. Blasetto, B. Bryzinski, Richard Caplan, A. Gold (2003)
The statin warsThe Lancet, 362
-
Kaeble-Elliott Ra, J. Tudor, Williams Jt (1964)
ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING.Lancet, 2 7367
-
P. Mismetti (2003)
Prevention of venous thromboembolism after major orthopedic surgery: ‘new’ clinical trials for new antithrombotic agentsJournal of Thrombosis and Haemostasis, 1
-
A. Turpie, K. Bauer, B. Eriksson, M. Lassen (2002)
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialThe Lancet, 359
-
K. Bauer, B. Eriksson, M. Lassen, A. Turpie (2001)
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.The New England journal of medicine, 345 18
-
R. Hull, Natasha Burke, A. Mah, G. Pineo (2003)
Timing of Initial Administration of Prophylaxis Against Deep Vein Thrombosis in Patients Following Hip or Knee SurgerChest, 124
-
R. Bauersachs (2005)
Fondaparinux: an update on new study resultsEuropean Journal of Clinical Investigation, 35
-
Peter Swedko, H. Clark, Koushi Paramsothy, A. Akbari (2003)
Serum creatinine is an inadequate screening test for renal failure in elderly patients.Archives of internal medicine, 163 3
-
A. Turpie, K. Bauer, B. Eriksson, M. Lassen (2002)
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.Archives of internal medicine, 162 16
-
R. Hull, G. Pineo, C. Francis, D. Bergqvist, C. Fellenius, K. Soderberg, A. Holmqvist, M. Mant, R. Dear, B. Baylis, A. Mah, R. Brant (2000)
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients : A double-blind, randomized comparisonJAMA Internal Medicine, 160
-
R.D. Hull, G.F. Pineo, C. Francis (2000)
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial InvestigatorsArch Intern Med, 160
-
Bomzer Ca (2001)
Heparin-induced thrombocytopenia.The New England Journal of Medicine, 345
-
B. Eriksson, P. Kälebo, David Bergqvisty, O. Dahl, S. Lindbratt, A. Bylock, L. Frison, UG Eriksson, L. Welin, D. Gustafsson (2002)
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trialThe Lancet, 360
-
C. Colwell, S. Berkowitz, J. Lieberman, P. Comp, Jeffrey Ginsberg, G. Paiement, J. McElhattan, Anne Roth, C. Francis (2005)
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.The Journal of bone and joint surgery. American volume, 87 10
-
W. Geerts, G. Pineo, J. Heit, D. Bergqvist, M. Lassen, C. Colwell, J. Ray (2004)
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest, 126 3 Suppl
-
G. Albers, H. Diener, L. Frison, M. Grind, M. Nevinson, S. Partridge, J. Halperin, J. Horrow, S. Olsson, P. Petersen, A. Vahanian (2005)
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.JAMA, 293 6
-
K. Burnham, David Anderson (2003)
Model selection and multimodel inference : a practical information-theoretic approachJournal of Wildlife Management, 67
-
B. Eriksson, K. Bauer, M. Lassen, A. Turpie (2001)
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.The New England journal of medicine, 345 18
-
G. Agnelli, D. Bergqvist, A.T. Cohen (2005)
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgeryBr J Surg, 92
-
C. Francis, S. Berkowitz, P. Comp, J. Lieberman, Jeffrey Ginsberg, G. Paiement, G. Peters, Anne Roth, J. McElhattan, C. Colwell (2003)
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.The New England journal of medicine, 349 18
-
J. Eikelboom, D. Quinlan, J. Douketis (2001)
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trialsThe Lancet, 358
-
D. Bogchelman, R. Lappöhn, J. Janssens (1982)
TRIPLET PREGNANCY AFTER PULSATILE ADMINISTRATION OF GONADOTROPIN RELEASING HORMONEThe Lancet, 320
-
U. Eriksson, S. Johansson, P. Attman, H. Mulec, L. Frison, Gunnar Vager, O. Samuelsson (2003)
Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous MelagatranClinical Pharmacokinetics, 42
-
R. Hull, G. Pineo, P. Stein, A. Mah, Matthew Butcher, Rollin Brant, D. Bergqvist, K. Hamulyák (2001)
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.Archives of internal medicine, 161 16
-
T. Horlocker, D. Wedel, H. Benzon, David Brown, K. Enneking, J. Heit, M. Mulroy, R. Rosenquist, J. Rowlingson, M. Tryba, C. Yuan (2003)
Regional Anesthesia in the Anticoagulated Patient: Defining the Risks (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation)Regional Anesthesia & Pain Medicine, 28
-
B. Eriksson (2005)
Ximelagatran in Orthopaedic SurgeryPathophysiology of Haemostasis and Thrombosis, 34
-
Bengt Eriksson, Peer Wille-Jørgensen, P. Kälebo, P. Mouret, N. Rosencher, Peter Bosch, Markus Baur, Steffan Ekman, Doris Bach, S. Lindbratt, Philippe Close (1997)
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.The New England journal of medicine, 337 19
-
E. Korn, P. Albert, L. McShane (2005)
Assessing surrogates as trial endpoints using mixed modelsStatistics in Medicine, 24
-
S. Marlovits (2002)
Prevention of venous thromboembolism with fondaparinux.The New England journal of medicine, 346 12
-
S. Schulman, K. Wåhlander, Torbjörn Lundström, Solveig Clason, H. Eriksson (2003)
Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.The New England journal of medicine, 349 18
-
O. Dahl, T. Aspelin, T. Lyberg (1995)
The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigsBlood Coagulation & Fibrinolysis, 6
-
G. Sanderink, C. Guimart, M. Ozoux, N. Jariwala, U. Shukla, B. Boutouyrie (2002)
Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment.Thrombosis research, 105 3
-
M.R. Lassen, K.A. Bauer, B.I. Eriksson (2002)
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonLancet, 359
-
C. Colwell, S. Berkowitz, B. Davidson, P. Lotke, Jeffrey Ginsberg, J. Lieberman, J. Neubauer, J. McElhattan, G. Peters, C. Francis (2003)
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double‐blind studyJournal of Thrombosis and Haemostasis, 1
-
U. Gruber, F. Duckert, R. Fridrich, J. Rem, J. Torhorst, V. Kakkar, Corrigan Tp, Fossard Dp, I. Sutherland, J. Thirlwell (1977)
PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW-DOSE HEPARINThe Lancet, 309
-
R. Hull, G. Pineo (2001)
A synthetic pentasaccharide for the prevention of deep-vein thrombosis.The New England journal of medicine, 345 4
-
N. Strebel, M. Prins, G. Agnelli, H. Büller (2002)
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?Archives of internal medicine, 162 13
-
William Geerts, J. Ray, C. Colwell, D. Bergqvist, G. Pineo, M. Lassen, J. Heit (1994)
Prevention of venous thromboembolism.Chest, 128 5
-
S. Vormfelde (2002)
Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgeryThe Lancet, 360
-
Agnes Lee (2005)
Management of thrombosis in cancer: primary prevention and secondary prophylaxisBritish Journal of Haematology, 128
-
O.E. Dahl, B.I. Eriksson, G. Agnelli (2005)
Postoperative melagatran/ximelagatran for the prevention of venous thromboembolism following major elective orthopaedic surgery: effects of timing of first dose and risk factors for thromboembolism and bleeding complications on efficacy and safetyClin Drug Investig, 25
-
A. Gallus, J. Hirsh, R. Tuttle, R. Trebilcock, Stephen O'Brien, Joseph Carroll, Joseph Minden, S. Hudecki (1973)
Small subcutaneous doses of heparin in prevention of venous thrombosis.The New England journal of medicine, 288 11
-
B. Olsson (2003)
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 362
-
N.A. Reynolds, C.M. Perry, L.J. Scott (2004)
Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgeryDrugs, 64
-
G. Raskob, J. Hirsh (2003)
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.Chest, 124 6 Suppl
- Publisher
- Springer Journals
- Copyright
- Copyright © 2007 by Adis Data Information BV
- Subject
- Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- DOI
- 10.2165/00129784-200707010-00001
- pmid
- 17355162
- Publisher site
- See Article on Publisher Site
Abstract
European surgeons generally administer thromboprophylaxis with low-molecular-weight heparins (LMWHs) at high doses 12 hours preoperatively in response to findings that surgery-related deep-vein thrombosis typically originates at the time of major orthopedic surgery or shortly afterwards. North American surgeons, in contrast, generally administer LMWHs at an almost 50% higher dose than that given in Europe 12–24 hours postoperatively, even though both pre- and postoperative administration are considered suitable in current guidelines. This review therefore examines how close to major orthopedic surgery thromboprophylaxis is administered, and the subsequent effect of timing on clinically relevant efficacy and safety parameters. The trials examined involve fondaparinux sodium (fondaparinux) and (xi)melagatran, in comparison with the established LMWHs enoxaparin sodium (enoxaparin) and dalteparin.
Journal
American Journal of Cardiovascular Drugs – Springer Journals
Published: Aug 20, 2012